Rubio C A, Kumagai J, Kanamori T, Yanagisawa A, Nakamura K, Kato Y
Department of Pathology, Karolinska Institute, Stockholm, Sweden.
Dis Colon Rectum. 1995 Oct;38(10):1075-9. doi: 10.1007/BF02133981.
In recent years, flat adenomas of the colorectal mucosa have been intensively investigated by Japanese pathologists. Results of that work indicate that flat adenomas may antedate the development of colorectal carcinomas. Because of differences in the histologic definition of flat adenomas with severe dysplasia and with intramucosal carcinoma within the group, one single observer having both Western and Asian training in pathology reviewed the material.
A total of 287 flat colorectal lesions were reviewed: 109 from the Karolinska Hospital, Stockholm, 137 from the Tokyo Medical and Dental University (TMDU) (which included 5 cases from the Nagoya City University), and 41 from the Cancer Institute (CI), Tokyo. Lesions were histologically classified following strict histologic criteria. Thus, flat adenomas were divided into those having low-grade dysplasia (LGD; having dysplastic cells in the deeper half of the epithelium), high-grade dysplasia (HGD; dysplastic cells were found even in the superficial half of the epithelium), intramucosal carcinoma (dysplastic glands displayed molding with buddings and often a cribriform pattern), and adenocarcinoma (braking through the muscularis mucosa, with neoplastic cells in the submucosal layer or deeper).
Whereas in Stockholm only 14.7 percent of lesions had HGD, as much as 56.9 percent and 56.1 percent, respectively, had HGD at the two Tokyo Hospitals. Intramucosal carcinomas were not found in the Stockholm material but occurred in 2.2 percent of lesions seen at TMDU and in 4.9 percent of those seen at the CI. Notably, only 2.7 percent of the specimens at Karolinska Hospital had invasive adenocarcinoma, but it was seen in as many as 4.4 percent at TMDU and 21.9 percent at the CI.
This study indicates that there were histologic differences between flat neoplasias of the colorectal mucosa harvested in Stockholm and Tokyo. In Japan lesions were obviously more advanced (in terms of HGD) and more aggressive (in terms of intramucosal and submucosal invasion). The cause for the differences found in those two disparate geographic regions remains poorly understood. The results, however, may help us understand some of the unclear points and discussions appearing in the literature on this subject.
近年来,日本病理学家对大肠黏膜扁平腺瘤进行了深入研究。该研究结果表明,扁平腺瘤可能先于大肠癌的发生。由于该组中重度发育异常的扁平腺瘤与黏膜内癌在组织学定义上存在差异,因此由一位接受过西方和亚洲病理学培训的单一观察者对材料进行了审查。
共审查了287个大肠扁平病变:109个来自斯德哥尔摩的卡罗林斯卡医院,137个来自东京医科齿科大学(TMDU)(其中包括5个来自名古屋市立大学的病例),41个来自东京癌症研究所(CI)。根据严格的组织学标准对病变进行组织学分类。因此,扁平腺瘤分为低级别发育异常(LGD;上皮深层有发育异常细胞)、高级别发育异常(HGD;上皮浅层甚至也发现有发育异常细胞)、黏膜内癌(发育异常腺体呈现出芽状的成型,且常呈筛状模式)和腺癌(突破黏膜肌层,黏膜下层或更深层有肿瘤细胞)。
在斯德哥尔摩,只有14.7%的病变有高级别发育异常,而在东京的两家医院,分别有高达56.9%和56.1%的病变有高级别发育异常。在斯德哥尔摩的材料中未发现黏膜内癌,但在东京医科齿科大学所见病变中有2.2%出现了黏膜内癌,在癌症研究所所见病变中有4.9%出现了黏膜内癌。值得注意的是,卡罗林斯卡医院只有2.7%的标本有浸润性腺癌,但在东京医科齿科大学有多达4.4%的标本出现浸润性腺癌,在癌症研究所有21.9%的标本出现浸润性腺癌。
本研究表明,在斯德哥尔摩和东京采集的大肠黏膜扁平肿瘤之间存在组织学差异。在日本,病变明显更高级(就高级别发育异常而言)且更具侵袭性(就黏膜内和黏膜下浸润而言)。在这两个不同地理区域发现差异的原因仍知之甚少。然而,这些结果可能有助于我们理解关于该主题的文献中出现的一些不明之处和讨论。